The Valley Desk

Clinical trial reportJournal of the American Academy of DermatologyPublished

Efficacy and safety of litifilimab in cutaneous lupus erythematosus: 24-week results of the randomized phase 2 study, AMETHYST

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Penn Medicine, Philadelphia VA Medical Center, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of the American Academy of Dermatology
Published
Subject terms
Safety; efficacy; Clinical Trial; Cutaneous Lupus Erythematosus; Pdcs; Phase 2; Ifn-i; Litifilimab; Cla-iga-r; Clasi-a
PubMed ID
42892381
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal